Episode 327: Neal and Toby examine how the latest jobs report may look promising, but not particularly for college graduates who may struggle with finding a job. Then, good, bad, and ugly news: the cargo ship cleanup at the Baltimore bridge crash site, OpenAI is changing its voice, and Red Lobster files for bankruptcy, respectively. Next, Hims & Hers Health ... Show More
Jul 15
JPMorgan Has Historic Q2 & New York Temporarily Bans Data Centers
#889: Welcome Ray and Kyle! Today, the guys break down a flurry of bank earnings yesterday, including a record-setting quarter from JPMorgan. Next up, what Fed Chair Kevin Warsh said about inflation in congress and what the latest CPI data says. Then, New York temporarily bans da ... Show More
28m 27s
Aug 2025
Entry-Level Jobs at Risk, CEOs Face Uncertainty, Tariffs & Textile Companies, Powering Data Centers
This week, college graduates struggle to find entry-level jobs - is AI part of the problem? And, Centerview Partners’ Blair Effron on CEOs weathering policy uncertainty, and the importance of New York's next mayor to the city's business community. Plus, how will President Trump’s ... Show More
48 m
Aug 2025
Team Favorite: Entry-Level Jobs at Risk, CEOs Face Uncertainty, Tariffs & Textile Companies, Powering Data Centers
Note: This is a re-air from August 8th 2025 This week, college graduates struggle to find entry-level jobs - is AI part of the problem? And, Centerview Partners’ Blair Effron on CEOs weathering policy uncertainty, and the importance of New York's next mayor to the city's business ... Show More
48 m
Aug 2024
👁️ “Nvidia’s watch party” — A.I.'s Biggest Day. Mister Softee’s soft-serve biz. Ozempic’s Direct-To-Tummy.
Nvidia just announced earnings that were so big, people hosted parties… but the results were a Rorschach Test for Wall Street.Mister Softee’s ice cream trucks have shrank in number by two thirds… because of competition, climate change, and street corners.Ozempic has a new strateg ... Show More
23m 43s
Feb 2024
The obesity drug craze is entering its next phase
Eli Lilly and Novo Nordisk can’t keep up with demand for their weight loss medications. In this Viewsroom podcast, Breakingviews columnists discuss the hype among celebrities, the different approaches to prescribing them in the US and Europe, and how they can reshape the world. V ... Show More
22m 46s
Oct 2023
Congress in Chaos, The Ozempic Effect, and the Healthcare Strike
Kara and Scott discuss declining social media traffic to news sites, Amazon using an algorithm to test how high they could boost prices, and why the boom in weight loss drugs is the “biggest business story of the year.” Also, Kevin McCarthy’s historic ouster marks another predict ... Show More
1h 4m